About Company
GenderAqua Biotech Co., Ltd. is a pioneering company dedicated to advancing aquacultural juvenile gender control technology within the aquaculture sector. We specialize in innovative biotechnology and novel aquaculture techniques, focusing on gender control through oral administration. This method replaces traditional manual injections and surgery, reducing both stress and labor costs. It accelerates farming, shortening the cycle and ensuring that livestock reaches harvestable weight within a specific timeframe. Committed to creating a more sustainable and inclusive aquaculture industry, we continuously invest in research and capacity-building. Our team adeptly employs both B2B (Business-to-Business) and B2C (Business-to-Consumer) sales models, enabling us to engage with a diverse range of stakeholders from industry partners to end consumers. We have also cultivated strong relationships with several Southeast Asian countries, including Vietnam, Malaysia, and Thailand, and as our technology gains wider acceptance, we aspire to expand our solutions globally, tapping into new markets.
Product Name
Healthy mostly-male giant freshwater prawn juvenile
Product Info
In the cultivation of giant freshwater prawns, it has been observed that males exhibit superior growth rates and command higher market prices compared to females. Leveraging our innovative gender control technique, we have successfully increased the proportion of male juveniles in a given batch from 25% to an impressive 70% or more. This significant shift in gender ratio has the potential to reduce the farming cycle by one month, thereby increasing the number of prawn batches that can be cultivated each year and effectively mitigating farming risks. Our novel farming model also reduces basic utility costs, enhances feed efficiency, and expedites the attainment of harvest maturity specifications, thereby catering to the substantial market demand more effectively. The cultivation of high-priced male prawns is projected to boost aquaculture profits substantially, with estimates suggesting a potential increase of 5 to 10 times. This revolutionary approach is poised to dramatically enhance the economic viability of the aquaculture industry.
Product Solutions
In the giant freshwater prawn industry, raising a batch of prawns to meet market specifications typically requires 5 to 6 months. Recently, these prawns have encountered significant challenges from diseases such as Infectious Precocity Virus (IPV), Enterocytozoon Hepatopenaei (EHP), and Shrimp Hemocyte Iridescent Virus (SHIV). These diseases cause high mortality rates and impede the growth of prawn populations. Our innovative approach involves using healthy, mostly-male giant freshwater prawn juveniles. Through careful observation, we have noted that these juveniles demonstrate rapid growth, attain larger sizes, and exhibit robust health. By shortening the farming cycle, our method not only reduces the risk of disease but also enables farmers to cultivate multiple batches of prawns within a year. This boost in productivity leads to increased income for farmers and advances aquaculture practices.
Product Image
Company Image
Brochure
Get in touch directly with us.
+886-2-7756-1768
6F., No. 26, Sec. 3, Nanjing E. Rd., Zhongshan Dist., Taipei City 104103 , Taiwan
